HALO logo

Halozyme Therapeutics (HALO)

Profile

Full Name

Halozyme Therapeutics, Inc.

Ticker Symbol

HALO

Exchange

NASDAQ

Country

United States

IPO

March 16, 2004

Indexes

Not included

Employees

350

Key Details

Price

$63.00

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$1.02B(+22.44% YoY)

Annual EPS

$3.43(+63.33% YoY)

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 6, 25 HC Wainwright & Co.
Buy
Feb 20, 25 Benchmark
Buy
Feb 19, 25 HC Wainwright & Co.
Buy
Feb 4, 25 HC Wainwright & Co.
Buy
Jan 13, 25 Wells Fargo
Equal-Weight
Jan 10, 25 Piper Sandler
Neutral
Jan 10, 25 HC Wainwright & Co.
Buy
Dec 30, 24 HC Wainwright & Co.
Buy
Dec 18, 24 HC Wainwright & Co.
Buy
Nov 25, 24 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Halozyme Therapeutics?
  • Does Halozyme Therapeutics pay dividends?
  • What sector is Halozyme Therapeutics in?
  • What industry is Halozyme Therapeutics in?
  • What country is Halozyme Therapeutics based in?
  • When did Halozyme Therapeutics go public?
  • Is Halozyme Therapeutics in the S&P 500?
  • Is Halozyme Therapeutics in the NASDAQ 100?
  • Is Halozyme Therapeutics in the Dow Jones?
  • When was Halozyme Therapeutics's last earnings report?
  • When does Halozyme Therapeutics report earnings?
  • Should I buy Halozyme Therapeutics stock now?

What is the ticker symbol for Halozyme Therapeutics?

The ticker symbol for Halozyme Therapeutics is NASDAQ:HALO

Does Halozyme Therapeutics pay dividends?

No, Halozyme Therapeutics does not pay dividends

What sector is Halozyme Therapeutics in?

Halozyme Therapeutics is in the Healthcare sector

What industry is Halozyme Therapeutics in?

Halozyme Therapeutics is in the Biotechnology industry

What country is Halozyme Therapeutics based in?

Halozyme Therapeutics is headquartered in United States

When did Halozyme Therapeutics go public?

Halozyme Therapeutics's initial public offering (IPO) was on March 16, 2004

Is Halozyme Therapeutics in the S&P 500?

No, Halozyme Therapeutics is not included in the S&P 500 index

Is Halozyme Therapeutics in the NASDAQ 100?

No, Halozyme Therapeutics is not included in the NASDAQ 100 index

Is Halozyme Therapeutics in the Dow Jones?

No, Halozyme Therapeutics is not included in the Dow Jones index

When was Halozyme Therapeutics's last earnings report?

Halozyme Therapeutics's most recent earnings report was on Feb 18, 2025

When does Halozyme Therapeutics report earnings?

The next expected earnings date for Halozyme Therapeutics is May 7, 2025

Should I buy Halozyme Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page